Fw: B-GE: update on FDA GE meetings dates

[Wesley Roe and Marjorie Lakin Erickson]

>In a message dated 10/25/99 7:44:43 PM, Robyn at WILDOATS.com writes:
>
><< Here's some additional information on the FDA genetic engineering
meetings:
>
>11/18/99 - Chicago, IL. One Prudential Plaza, Plaza Club, 40th Floor, 130
>East Randolph St., Chicago. 9 a.m. to 6 p.m.
>11/30/99 - Washington, D.C. Grand Hyatt Washington, 1000 H St. NW,
>Washington, D.C. 10 a.m. to 7 p.m.
>12/13/99 - Oakland, CA. Elihu Harris State Office Building, 1515 Clay St.,
>Oakland, CA. 9 a.m. to 6 p.m.
>
>If you'd like to attend you must register with the appropriate contact
>person 15 days prior to the meeting you wish to attend, by providing your
>name, title, business affiliation, address, telephone and fax number. If,
in
>addition to attending, you wish to make an oral presentation during the
>meeting, you must so inform the contact person when you register and
submit:
>(1) a brief written statement of the general nature of the views you wish
to
>present; (2) the names and addresses of all persons who will participate in
>the presentation; and (3) an indication of the approximate time that you
>request to make your presentation. Depending upon the number of people who
>register, FDA may have to limit the time allotted for each presentation.
>
>for general info: Nega Beru, Center for Food Safety & Applied Nutrition,
>FDA, (202) 418-3090; fax (202) 418-3131; e: nberu at bangate.fda.gov
>
>to register for Chicago: Darlene Bailey, Chicago District, FDA, (312)
>353-7126; fax (312) 886-3280; e: dbailey at ora.fda.gov
>
>to register for Washington, D.C.: Patricia Alexander, Office of Consumer
>Affairs, FDA, (301) 827-5006; fax (301) 827-3052; e:palexand at oc.fda.gov
>
>to register for Oakland: Janet McDonald, San Francisco District, FDA, (510)
>337-6845; fax (510) 337-6708; e: jmcdonal at ora.fda.gov
>
>Summary: The Food & Drug Administration (FDA) is announcing three public
>meetings on issues within FDA's jurisdiction related to foods (both human
>and animal) derived from plants developed using bioengineering techniques.
>The purpose of these public meetings is for the agency to share its current
>approach and experience over the past 5 years regarding safety evaluation
>and labeling of food products derived from bioengineered plant varieties,
to
>solicit views on whether FDA's policies or procedures should be modified,
>and to gather information to be used to assess the most appropriate means
of
>providing information to the public about bioengineered products in the
food
>supply.These meetings will afford consumers, industry and academia an
>opportunity to provide focused comment on these issues in a manner that
will
>assist FDA in evaluating and refining its existing policies and procedures.
>
>There also is a written comment period, through January 13, 2000.
>
>Robyn Nick
>Wild Oats Markets, Inc.
>http://www.wildoats.com
>
>----
>For instructions on joining, leaving, or otherwise using the Ban-GEF list,
>send email to Ban-GEF at lists.txinfinet.com with HELP in the SUBJECT line.
>----

>
>
>